To ensure the right decision is made for individuals going through a disability determination, benefits agencies and organizations should utilize medical professionals and specialists to achieve well-informed conclusions, according to a UMass Medical School disability evaluation expert.
Hepatitis C is one of the top public health challenges facing the U.S., with as many as three to four million people currently living with this “chronic infection,” notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
Access to a wide variety of professionals in different specialties is imperative for independent disability reviewers when making a determination, according to the disability determinations medical director at UMass Medical School.
How UMass Medical School is helping MassHealth, the Massachusetts Medicaid program, promote more rational use of opioids is highlighted in a Specialty Pharmacy Continuum article on managed care efforts to address the nationwide addiction crisis.
Pairing patients up with the right medications, sending refill reminders and tracking results are all ingredients for a successful hepatitis C medication management program, says UMass Medical School pharmacy expert.
Amid a nationwide opioid addiction crisis, payers must look well beyond simply containing costs and work closely with doctors who are prescribing these powerful pain medications, says Tyson Thompson, PharmD, a clinical consultant pharmacist at UMass Medical School.
UMass Medical School has won national recognition for its use of technology to help connect seniors and people with disabilities with long-term services and supports. Created in 2015, MassOptions is a phone support line and website that provides referrals to day services, in-home supports, equipment and supplies, and mental health and personal care services.
As efforts mount to rein in relentlessly rising medical costs, there are “going to be winners and losers” among health care organizations as they grapple with an inevitable decline in revenue, says UMass Medical School’s Robert W. Seifert, MPA.
Alaska’s success in heading off looming rate increases under the Affordable Care Act (ACA) provides a potential roadmap for states interested in using a federal waiver process to change their local health care markets, notes UMass Medical School health care law and policy expert Rachel Gershon, JD, MPH.
The U.S. departments of Health and Human Services and Treasury on July 11 announced approval of Alaska’s 1332 waiver.
Missouri’s largest retirement system for local government workers has partnered with UMass Medical School’s Disability Evaluation Services to provide enhancements and support for its disability certification and re-certification process.
Wells Fargo, a USBLN Corporate Partner and Founding Partner of the USBLN Disability Supplier Diversity Program (DSDP®), will provide generous financial support to aid these efforts with a grant to the Massachusetts Business Leadership Network (MABLN), a program of UMass Medical School’s Work Without Limits (WWL).
The New England Newborn Screening Program, operated by UMass Medical School for the Massachusetts Department of Public Health, will begin a voluntary pilot screening program for spinal muscular atrophy (SMA), as a result of the availability of a new FDA-approved therapy for the genetic disorder.
A disability inclusion leader who is also the father of a child with a disability will be one of several key speakers at the Raise the Bar Hire! Conference October 5-6 hosted by UMass Medical School’s Work Without Limits.
Federal regulations on the treatment of the “medically frail” could in fact provide an “opportunity” for states which seek to expand their Medicaid programs in the future, notes Sherry Campanelli, MPA, disability evaluation expert at UMass Medical School.
States still moving ahead with Medicaid expansion face an added challenge: Setting up systems to identify and properly enroll “medically frail” individuals, notes Sherry Campanelli, a disability evaluation expert at UMass Medical School.